Eindhoven, Netherlands

Christoph Neukirchen

This inventor holds 1 USPTO granted patent. Top assignee: Koninklijke Philips Corporation N.v.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christoph Neukirchen. Retrieved from https://idiyas.com/inventor/christoph-neukirchen-ctcmbhz2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Christoph Neukirchen and His Patent in Focal Therapy Planning.

Introduction

Christoph Neukirchen is an inventor associated with Eindhoven, Netherlands, and Koninklijke Philips N.V. His patent work concerns treatment planning for focal therapy, an approach that targets a specific structure within a patient’s body.

Latest Patents

Neukirchen is associated with 1 patent: “Treatment Planning for Focal Therapy Treatments.” The invention describes a system that assists with planning focal therapy by applying a treatment quantity through one or more devices positioned for treatment. The system generates a constraint function representing clinical objectives, compares candidate device positions using sums of negative derivatives of that function, selects a position, and optimizes at least one treatment parameter for it.

Career Highlights

His listed patent reflects work on computational support for focal therapy planning. By combining clinical constraints, device-position selection, and treatment-parameter optimization, the system is designed to help structure the planning process.

Collaborations

The provided information lists Guillaume Leopold Theodorus Frederik Hautvast and Alfonso Agatino Isola as Neukirchen’s coworkers. His company is Koninklijke Philips N.V.

Conclusion

Christoph Neukirchen’s patent work focuses on a system for selecting device positions and optimizing treatment parameters in focal therapy planning.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…